---
figid: PMC5993488__koni-07-07-1445458-g003
figtitle: Cumulative HLA class I and APM defects across gliomas from TCGA
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC5993488
filename: koni-07-07-1445458-g003.jpg
figlink: /pmc/articles/PMC5993488/figure/f0002b/
number: F2b
caption: Cumulative HLA class I and APM defects across gliomas from TCGA. (A) 213/396 GBM
  and (B) 166/511 LGG samples were found to have alterations in the formation of the
  HLA class I peptide complex that enable glioma cells to escape immune recognition
  by CD8+ T-cells. (C) Highlighted in red are the components showing different types
  of alterations in antigen processing and presentation ranging from defects in the
  IFN-γ pathway (JAK1, JAK2, STAT1) and the HLA class I enhanceosome (NLRC5, CIITA,
  IRF1, RFX5, RFXANK, RFXAP, X2BP, NF-Y) that mediate the transcriptional activation
  of HLA class I genes; PSME1, PSME2, PSME3 genes coding for the alpha, beta, and
  gamma subunits that make up the proteasome activator complex PA28 for peptide generation;
  ERAP1 and ERAP2 that trim longer precursor of antigenic peptides; HSPA and HSPC
  that chaperones the peptides to their loading on the MHC class I in the endoplasmic
  reticulum; and TAP1, TAP2, TAPBP, calreticulin, calnexin, PDIA3, β2-microglobulin
  and HLA class I genes that participate in the formation of the MHC class I peptide
  complex.
papertitle: The possibility of cancer immune editing in gliomas. A critical review.
reftext: Víctor A. Arrieta, et al. Oncoimmunology. 2018;7(7):e1445458.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8990305
figid_alias: PMC5993488__F2b
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC5993488__F2b
ndex: c86b7732-df13-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5993488__koni-07-07-1445458-g003.html
  '@type': Dataset
  description: Cumulative HLA class I and APM defects across gliomas from TCGA. (A)
    213/396 GBM and (B) 166/511 LGG samples were found to have alterations in the
    formation of the HLA class I peptide complex that enable glioma cells to escape
    immune recognition by CD8+ T-cells. (C) Highlighted in red are the components
    showing different types of alterations in antigen processing and presentation
    ranging from defects in the IFN-γ pathway (JAK1, JAK2, STAT1) and the HLA class
    I enhanceosome (NLRC5, CIITA, IRF1, RFX5, RFXANK, RFXAP, X2BP, NF-Y) that mediate
    the transcriptional activation of HLA class I genes; PSME1, PSME2, PSME3 genes
    coding for the alpha, beta, and gamma subunits that make up the proteasome activator
    complex PA28 for peptide generation; ERAP1 and ERAP2 that trim longer precursor
    of antigenic peptides; HSPA and HSPC that chaperones the peptides to their loading
    on the MHC class I in the endoplasmic reticulum; and TAP1, TAP2, TAPBP, calreticulin,
    calnexin, PDIA3, β2-microglobulin and HLA class I genes that participate in the
    formation of the MHC class I peptide complex.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Jak2
  - Irf1
  - Ciita
  - Creb1
  - Nfya
  - Pdia3
  - Tap2
  - Polr3e
  - Das
  - Tapbp
  - Psmb9
  - Psmb8
  - Psme1
  - Trav6-3
  - Eo
  - Chil6
  - Psme3
  - CD8A
  - CD8B
  - IFNA1
  - JAK2
  - IRF1
  - CIITA
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - NFYA
  - PDIA3
  - TAP2
  - SEC14L3
  - EFS
  - POLR3E
  - LTBP3
  - TAPBP
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - HSPA12A
  - HSPA12B
  - HSPA13
  - HSPA14
  - HSPA1A
  - HSPA1B
  - HSPA1L
  - HSPA2
  - HSPA4
  - HSPA4L
  - HSPA5
  - HSPA6
  - HSPA8
  - HSPA9
  - HSPH1
  - HYOU1
  - ERAP2
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - HLA-C
  - TCR
  - TAPI
  - Glioma
---
